KEROS THERAPEUTICS INC shareholders Q3 2023

KEROS THERAPEUTICS INC's ticker is KROS and the CUSIP is 492327101. A total of 105 filers reported holding KEROS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

KEROS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Ameritas Investment Partners, Inc. 2,236$71,2840.00%
MetLife Investment Management, LLC 11,885$378,8940.00%
MILLENNIUM MANAGEMENT LLC 204,057$6,505,3370.00%
BALYASNY ASSET MANAGEMENT L.P. 44,989$1,434,2490.00%
STATE OF WISCONSIN INVESTMENT BOARD 26,708$851,4510.00%
STATE STREET CORP 902,000$28,755,7600.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 176,953$5,641,2620.00%
GEODE CAPITAL MANAGEMENT, LLC 486,001$15,495,6070.00%
BlackRock Inc. 1,867,349$59,531,0870.00%
CITIGROUP INC 98,109$3,127,7150.00%
DIMENSIONAL FUND ADVISORS LP 171,277$5,460,3110.00%
HighMark Wealth Management LLC 75$2,3910.00%
METROPOLITAN LIFE INSURANCE CO/NY 1,424$45,3970.00%
Renaissance Technologies 43,700$1,3930.00%
AMERICAN INTERNATIONAL GROUP, INC. 11,233$358,1080.00%
Nuveen Asset Management, LLC 71,018$2,264,0540.00%
Tower Research Capital LLC (TRC) 637$20,3080.00%
Allianz Asset Management GmbH 12,200$388,9360.00%
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND 7,000$223,1600.00%
BARCLAYS PLC 49,511$1,5780.00%
External links

This page lists KEROS THERAPEUTICS INC's shareholders in Q3 2023. To view KEROS THERAPEUTICS INC's shareholder history, click here.